Doctors share what you shouldn't be doing if you want to live a long and healthy life.

Novo Nordisk (NYSE: NVO) got fantastic news last year when regulators approved its weight loss pill. It's the first oral ...

The target action date for orforglipron is now April 10.

According to the Centers for Disease Control and Prevention, 41.9 percent of U.S. adults were obese from 2017 to 2020.

Lilly CEO Dave Ricks is confident in the ability of the company's pill to compete and is preparing for a "full launch" in the ...